Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1956 1
1960 1
1961 1
1962 2
1963 4
1964 10
1965 7
1966 5
1967 4
1968 11
1969 10
1970 9
1971 7
1972 12
1973 11
1974 16
1975 22
1976 7
1977 26
1978 12
1979 18
1980 17
1981 12
1982 20
1983 19
1984 18
1985 18
1986 17
1987 10
1988 23
1989 29
1990 23
1991 16
1992 20
1993 24
1994 22
1995 14
1996 21
1997 25
1998 25
1999 24
2000 21
2001 23
2002 24
2003 42
2004 33
2005 47
2006 47
2007 67
2008 64
2009 62
2010 55
2011 61
2012 59
2013 91
2014 112
2015 110
2016 125
2017 119
2018 116
2019 94
2020 106
2021 124
2022 133
2023 112
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

2,224 results

Results by year

Filters applied: . Clear all
Page 1
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.
Tefferi A. Tefferi A. Am J Hematol. 2021 Jan;96(1):145-162. doi: 10.1002/ajh.26050. Epub 2020 Dec 2. Am J Hematol. 2021. PMID: 33197049 Free article. Review.
DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations. ...
DISEASE OVERVIEW: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal …
A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management.
Garmezy B, Schaefer JK, Mercer J, Talpaz M. Garmezy B, et al. Blood Rev. 2021 Jan;45:100691. doi: 10.1016/j.blre.2020.100691. Epub 2020 Apr 7. Blood Rev. 2021. PMID: 32354563 Review.
Although understanding of the pathogenesis and molecular biology of primary myelofibrosis continues to improve, treatment options are limited, and several biological features remain unexplained. ...
Although understanding of the pathogenesis and molecular biology of primary myelofibrosis continues to improve, treatment opti …
Pediatric Myeloproliferative Neoplasms.
El-Sharkawy F, Margolskee E. El-Sharkawy F, et al. Clin Lab Med. 2021 Sep;41(3):529-540. doi: 10.1016/j.cll.2021.04.010. Clin Lab Med. 2021. PMID: 34304780 Review.
This article focuses on chronic myeloid leukemia, essential thrombocythemia, polycythemia vera, and primary myelofibrosis in children....
This article focuses on chronic myeloid leukemia, essential thrombocythemia, polycythemia vera, and primary myelofibrosis in c …
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
Cervantes F, Dupriez B, Pereira A, Passamonti F, Reilly JT, Morra E, Vannucchi AM, Mesa RA, Demory JL, Barosi G, Rumi E, Tefferi A. Cervantes F, et al. Blood. 2009 Mar 26;113(13):2895-901. doi: 10.1182/blood-2008-07-170449. Epub 2008 Nov 6. Blood. 2009. PMID: 18988864 Free article.
Therapeutic decision-making in primary myelofibrosis (PMF) is becoming more challenging because of the increasing use of allogeneic stem cell transplantation and new investigational drugs. ...
Therapeutic decision-making in primary myelofibrosis (PMF) is becoming more challenging because of the increasing use of allog …
Diagnosis and management of prefibrotic myelofibrosis.
Rumi E, Sant'Antonio E, Boveri E, Pietra D, Cavalloni C, Roncoroni E, Astori C, Arcaini L; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. Rumi E, et al. Expert Rev Hematol. 2018 Jul;11(7):537-545. doi: 10.1080/17474086.2018.1484280. Epub 2018 Jun 22. Expert Rev Hematol. 2018. PMID: 29862872 Review.
The 2016 WHO classification comprises two stages of primary myelofibrosis (PMF): early/prefibrotic primary myelofibrosis (pre-PMF) and overt fibrotic PMF (overt PMF). ...
The 2016 WHO classification comprises two stages of primary myelofibrosis (PMF): early/prefibrotic primary myelofibr …
State-of-the-Art Review on Myelofibrosis Therapies.
Wang F, Qiu T, Wang H, Yang Q. Wang F, et al. Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e350-e362. doi: 10.1016/j.clml.2021.11.007. Epub 2021 Nov 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34903489 Review.
Primary myelofibrosis and its targeted therapy.
Shantzer L, Berger K, Pu JJ. Shantzer L, et al. Ann Hematol. 2017 Apr;96(4):531-535. doi: 10.1007/s00277-016-2785-9. Epub 2016 Aug 19. Ann Hematol. 2017. PMID: 27539616 Review.
Primary myelofibrosis is a unique entity among BCR-ABL-negative myeloproliferative diseases, manifesting as bone marrow fibrosis and pancytopenia. ...This study reviews current concepts and questions regarding the pathogenesis of primary myelofibrosis …
Primary myelofibrosis is a unique entity among BCR-ABL-negative myeloproliferative diseases, manifesting as bone marrow fibros …
Distinguishing autoimmune myelofibrosis from primary myelofibrosis.
Marcellino B, El Jamal SM, Mascarenhas JO. Marcellino B, et al. Clin Adv Hematol Oncol. 2018 Sep;16(9):619-626. Clin Adv Hematol Oncol. 2018. PMID: 30256778 Review.
Autoimmune myelofibrosis (AIMF) is an uncommon etiology of BMF; it can be secondary to a defined autoimmune disease, or it can be primary in the absence of a clinically diagnosed autoimmune disease but the presence of serologic evidence of autoantibodies. Distinguishing between …
Autoimmune myelofibrosis (AIMF) is an uncommon etiology of BMF; it can be secondary to a defined autoimmune disease, or it can be primary in …
How I Diagnose Primary Myelofibrosis.
Prakash S, Orazi A. Prakash S, et al. Am J Clin Pathol. 2022 Apr 1;157(4):518-530. doi: 10.1093/ajcp/aqac016. Am J Clin Pathol. 2022. PMID: 35238345
OBJECTIVES: Primary myelofibrosis (PMF) is a BCR/ABL1-negative myeloproliferative neoplasm (MPN) with a shorter overall survival and a higher leukemic transformation than other BCR/ABL1-negative MPNs. ...
OBJECTIVES: Primary myelofibrosis (PMF) is a BCR/ABL1-negative myeloproliferative neoplasm (MPN) with a shorter overall surviv …
2,224 results